Overview
- 16 inspections across 16 sites are on record.
- 61 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-01-23.
At a glance
Inspections
16
Sites
16
Observations
61
Career since
Nov 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Veranova LP | 23 Jan 2026 | Human Drugs | On file |
| Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany | 8 Dec 2025 | Human Drugs | |
| PML NYC, LLC | 25 Sep 2025 | Human Drugs | On file |
| ChiRhoClin, Inc | 15 Sep 2025 | Human Drugs | On file |
| Supernus Pharmaceuticals, Inc. | 31 Jul 2025 | Human Drugs |
Sites inspected
Veranova LPWest Deptford, United States1 insp.
Halo Pharmaceutical, Inc. d/b/a Cambrex WhippanyWhippany, United States1 insp.
PML NYC, LLCLong Island City, United States1 insp.
ChiRhoClin, IncBurtonsville, United States1 insp.
Supernus Pharmaceuticals, Inc.Rockville, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Pushpa S Jayasekara5 shared
Michael O Idowu4 shared
Olumide A Akinyemi3 shared
David A Oluwo2 shared
Claude Noel Y Zanetsie2 shared
Syeda N Mahazabin2 shared
Ofuje D Daniyan1 shared
John D Mcintosh1 shared
Jenny Sung1 shared
Helen Verdel1 shared
Full investigator report
Get the verbatim findings behind Catherine O Lamptey's 61 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site